This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Trulieve Cannabis 향후 성장
Future 기준 점검 3/6
Trulieve Cannabis 의 수익은 연간 5.5% 감소할 것으로 예상되는 반면, 연간 수익은 124.5% 로 증가할 것으로 예상됩니다. EPS는 연간 49.8% 만큼 성장할 것으로 예상됩니다.
핵심 정보
124.5%
이익 성장률
49.79%
EPS 성장률
| Pharmaceuticals 이익 성장 | 15.9% |
| 매출 성장률 | -5.5% |
| 향후 자기자본이익률 | n/a |
| 애널리스트 커버리지 | Good |
| 마지막 업데이트 | 10 Jun 2026 |
최근 향후 성장 업데이트
Recent updates
내러티브 업데이트 • May 30
TRUL: Schedule III Reclassification Pathway Will Drive Future Multiple Re Rating
Narrative Update on Trulieve Cannabis Analysts have raised their price target on Trulieve Cannabis by CA$8, reflecting updated assumptions for fair value, revenue growth, profit margins, and future P/E following recent sector research and regulatory commentary on cannabis rescheduling. Analyst Commentary Street research around Trulieve Cannabis has centered on how potential cannabis rescheduling could affect valuation, tax burdens, and long term earnings power.내러티브 업데이트 • Apr 23
TRUL: Schedule III Shift And Repriced P E Multiple Will Drive Upside
Analysts raised their price target for Trulieve Cannabis to CA$15.26 from CA$14.95, citing updated assumptions based on higher modeled revenue growth, stronger profit margins, and a more moderate future P/E multiple. Analyst Commentary Street research on the broader equity market has included several cautious revisions and lower price targets, which can help frame how bearish analysts might approach a stock like Trulieve Cannabis.
내러티브 업데이트 • Apr 08
TRUL: Higher Margin Profile And Rich Future P/E May Support Repricing
Analysts have lifted their fair value estimate for Trulieve Cannabis to CA$20.36 from CA$19.53, citing updated assumptions that reflect more conservative revenue growth, a higher profit margin profile, and a very large future P/E multiple that aligns with recent Street research patterns of recalibrating price targets while keeping core views intact. Analyst Commentary Street research across sectors shows a pattern of price target resets that keep long term theses largely intact, and this context helps frame how to read the updated fair value for Trulieve Cannabis.내러티브 업데이트 • Mar 24
TRUL: Schedule III Shift And Lower P E Multiple Will Drive Upside
Analysts have nudged their fair value price target for Trulieve Cannabis to CA$14.95, reflecting updated assumptions for slightly higher revenue growth, modestly improved profit margins, and a lower future P/E multiple in their models. Analyst Commentary While the latest fair value update suggests analysts see some improvement in Trulieve Cannabis' revenue and margin profile, there is still a clear undercurrent of caution in recent research across adjacent data and credit reporting names that can inform how you think about risk.내러티브 업데이트 • Mar 10
TRUL: Schedule III Shift And Higher P E Assumptions Will Drive Future Upside
Analysts have slightly raised their fair value estimate for Trulieve Cannabis to about CA$14.95 from CA$14.69, reflecting updated assumptions around slower revenue growth, tighter profit margins and a much higher future P/E multiple that mirrors recent Street work, where price targets have been adjusted while views on long term earnings power and business mix continue to evolve. Analyst Commentary Street research around information services and data providers has recently highlighted how quickly sentiment can shift when investors question earnings durability, pricing power or the impact of new technology.내러티브 업데이트 • Feb 24
TRUL: Rescheduling To Schedule III Will Shape Future Upside Potential
Analysts have trimmed their price target on Trulieve Cannabis by a small amount to reflect a slightly lower fair value estimate of CA$14.69. This incorporates updated assumptions that include modestly adjusted revenue growth, profit margin outlook and future P/E expectations.분석 기사 • Feb 12
Some Confidence Is Lacking In Trulieve Cannabis Corp. (CSE:TRUL) As Shares Slide 30%
The Trulieve Cannabis Corp. ( CSE:TRUL ) share price has softened a substantial 30% over the previous 30 days, handing...내러티브 업데이트 • Feb 09
TRUL: Rescheduling To Schedule III Will Support Higher Future Earnings Multiples
Analysts have slightly raised their fair value estimate for Trulieve Cannabis to $19.53 from $19.06, citing updated assumptions around the discount rate, revenue growth, profit margins, and future P/E levels. What's in the News President Trump directed the Attorney General to complete the rulemaking process to reschedule marijuana to Schedule III of the Controlled Substances Act, which would apply to companies such as Trulieve Cannabis that operate in the sector (Marijuana Herald).내러티브 업데이트 • Jan 25
TRUL: Future Rescheduling And Tax Relief Prospects Will Shape Upside Potential
Analysts have trimmed their fair value estimate for Trulieve Cannabis by about $0.12 to roughly $14.78, reflecting updated assumptions around slightly higher revenue growth, a wider profit margin profile, and a lower future P/E multiple. Analyst Commentary Some bearish analysts are using the latest fair value trim as a reminder that execution and growth expectations for Trulieve Cannabis still carry meaningful risk, even with a higher revenue and margin outlook built into the model.내러티브 업데이트 • Jan 11
TRUL: Retail Expansion And Rescheduling Progress Will Support Higher Future Earnings Multiples
Analysts have made a small upward adjustment to their Trulieve Cannabis fair value estimate, reflecting only modest tweaks to long term profit margin and future P/E assumptions rather than a wholesale shift in their outlook. Analyst Commentary Recent Street research around comparable business services and data providers offers some useful clues for how analysts may be thinking about Trulieve Cannabis valuation and execution, even though the coverage is focused on different companies.내러티브 업데이트 • Dec 27
TRUL: Retail Expansion Into New States Will Drive Future Earnings Multiples
Analysts nudged their price target on Trulieve Cannabis slightly higher, by about $0.16, as they factor in stronger multi year revenue growth, improving profit margins, and a more reasonable future earnings multiple, while still maintaining a similar discount rate framework. Analyst Commentary Recent commentary around Trulieve Cannabis reflects a more constructive, yet still measured, stance as analysts incorporate updated assumptions for growth, profitability, and regulatory visibility into their valuation work.분석 기사 • Dec 22
Trulieve Cannabis Corp.'s (CSE:TRUL) Shares Climb 55% But Its Business Is Yet to Catch Up
Trulieve Cannabis Corp. ( CSE:TRUL ) shareholders would be excited to see that the share price has had a great month...내러티브 업데이트 • Dec 13
TRUL: Future Execution And Regulatory Shifts Will Shape Risk-Reward Balance
Analysts have lifted their price target on Trulieve Cannabis to approximately $14.90 from about $11.01, citing stronger expected revenue growth, improved profit margins, and a more reasonable future P/E multiple despite a slightly higher discount rate. Analyst Commentary Bearish analysts acknowledge Trulieve Cannabis's improved outlook but remain wary of execution and valuation risks in a still evolving regulatory and competitive landscape.내러티브 업데이트 • Nov 22
TRUL: Retail Expansion And New Markets Will Support Share Price Momentum
The analyst price target for Trulieve Cannabis has decreased slightly from $19.16 to $18.87. Analysts cite modest adjustments to profit margin expectations and valuation metrics as reasons for the change.분석 기사 • Nov 08
Trulieve Cannabis Corp. (CSE:TRUL) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Shareholders might have noticed that Trulieve Cannabis Corp. ( CSE:TRUL ) filed its quarterly result this time last...분석 기사 • Nov 07
Some Trulieve Cannabis Corp. (CSE:TRUL) Shareholders Look For Exit As Shares Take 29% Pounding
The Trulieve Cannabis Corp. ( CSE:TRUL ) share price has softened a substantial 29% over the previous 30 days, handing...내러티브 업데이트 • Nov 07
TRUL: Future Market Expansion Will Drive Share Price Momentum
Trulieve Cannabis’s analyst price target has been raised from $17.89 to $19.16. Analysts cite improved revenue growth projections and stable profit margins as key drivers for the upward revision.분석 기사 • Oct 27
We Think Trulieve Cannabis (CSE:TRUL) Is Taking Some Risk With Its Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...분석 기사 • Aug 29
Trulieve Cannabis Corp.'s (CSE:TRUL) Shares Climb 97% But Its Business Is Yet to Catch Up
Trulieve Cannabis Corp. ( CSE:TRUL ) shares have continued their recent momentum with a 97% gain in the last month...분석 기사 • Jul 11
Revenues Not Telling The Story For Trulieve Cannabis Corp. (CSE:TRUL) After Shares Rise 28%
Trulieve Cannabis Corp. ( CSE:TRUL ) shares have continued their recent momentum with a 28% gain in the last month...분석 기사 • Jun 12
Does Trulieve Cannabis (CSE:TRUL) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
새로운 내러티브 • Mar 25
Adult-Use Cannabis Expansion In Florida And Pennsylvania Will Broaden Markets
Strategic retail expansion and new market entry in key states could significantly boost revenue and market share by tapping into adult-use markets.분석 기사 • Jan 10
Here's Why Trulieve Cannabis (CSE:TRUL) Has A Meaningful Debt Burden
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...분석 기사 • Dec 05
More Unpleasant Surprises Could Be In Store For Trulieve Cannabis Corp.'s (CSE:TRUL) Shares After Tumbling 56%
Trulieve Cannabis Corp. ( CSE:TRUL ) shares have had a horrible month, losing 56% after a relatively good period...분석 기사 • Sep 04
Are Investors Undervaluing Trulieve Cannabis Corp. (CSE:TRUL) By 47%?
Key Insights The projected fair value for Trulieve Cannabis is CA$24.05 based on 2 Stage Free Cash Flow to Equity...분석 기사 • Jun 15
Trulieve Cannabis Corp.'s (CSE:TRUL) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Trulieve Cannabis Corp. ( CSE:TRUL ) shareholders won't be pleased to see that the share price has had a very rough...분석 기사 • Jun 06
Trulieve Cannabis Corp.'s (CSE:TRUL) CEO Will Probably Struggle To See A Pay Rise This Year
Key Insights Trulieve Cannabis' Annual General Meeting to take place on 12th of June Salary of US$750.0k is part of CEO...분석 기사 • May 01
Are Investors Undervaluing Trulieve Cannabis Corp. (CSE:TRUL) By 38%?
Key Insights The projected fair value for Trulieve Cannabis is CA$32.01 based on 2 Stage Free Cash Flow to Equity...분석 기사 • Mar 31
Revenues Not Telling The Story For Trulieve Cannabis Corp. (CSE:TRUL) After Shares Rise 26%
Trulieve Cannabis Corp. ( CSE:TRUL ) shares have continued their recent momentum with a 26% gain in the last month...분석 기사 • Feb 15
Is Trulieve Cannabis (CSE:TRUL) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...분석 기사 • Jan 16
There's Reason For Concern Over Trulieve Cannabis Corp.'s (CSE:TRUL) Massive 29% Price Jump
The Trulieve Cannabis Corp. ( CSE:TRUL ) share price has done very well over the last month, posting an excellent gain...이익 및 매출 성장 예측
| 날짜 | 매출 | 이익 | 자유현금흐름 | 영업현금흐름 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2028 | 901 | N/A | N/A | N/A | 1 |
| 12/31/2027 | 1,071 | 95 | 192 | 266 | 6 |
| 12/31/2026 | 1,093 | 58 | 180 | 251 | 7 |
| 3/31/2026 | 1,170 | -76 | 224 | 277 | N/A |
| 12/31/2025 | 1,181 | -111 | 212 | 273 | N/A |
| 9/30/2025 | 1,189 | -116 | 142 | 245 | N/A |
| 6/30/2025 | 1,185 | -155 | 67 | 198 | N/A |
| 3/31/2025 | 1,187 | -159 | 36 | 183 | N/A |
| 12/31/2024 | 1,186 | -149 | 124 | 272 | N/A |
| 9/30/2024 | 1,172 | -135 | 261 | 372 | N/A |
| 6/30/2024 | 1,163 | -97 | 362 | 437 | N/A |
| 3/31/2024 | 1,142 | -419 | 287 | 343 | N/A |
| 12/31/2023 | 1,129 | -431 | 156 | 207 | N/A |
| 9/30/2023 | 1,141 | -458 | 60 | 139 | N/A |
| 6/30/2023 | 1,161 | -508 | -91 | 23 | N/A |
| 3/31/2023 | 1,193 | -185 | -174 | -20 | N/A |
| 12/31/2022 | 1,218 | -179 | -172 | 21 | N/A |
| 9/30/2022 | 1,225 | -185 | -309 | -105 | N/A |
| 6/30/2022 | 1,153 | -95 | -300 | -58 | N/A |
| 3/31/2022 | 1,055 | -37 | -263 | -2 | N/A |
| 12/31/2021 | 932 | 31 | -301 | 9 | N/A |
| 9/30/2021 | 801 | 93 | -162 | 102 | N/A |
| 6/30/2021 | 714 | 91 | -156 | 71 | N/A |
| 3/31/2021 | 619 | 69 | -37 | 135 | N/A |
| 12/31/2020 | 522 | 63 | -47 | 100 | N/A |
| 9/30/2020 | 433 | -19 | -35 | 76 | N/A |
| 6/30/2020 | 367 | 23 | -11 | 77 | N/A |
| 3/31/2020 | 304 | 62 | -57 | 33 | N/A |
| 12/31/2019 | 253 | 53 | N/A | 19 | N/A |
| 9/30/2019 | 209 | 128 | N/A | 24 | N/A |
| 6/30/2019 | 167 | 85 | N/A | 36 | N/A |
| 3/31/2019 | 132 | 36 | N/A | 34 | N/A |
| 12/31/2018 | 103 | 11 | N/A | 24 | N/A |
| 9/30/2018 | 80 | 33 | N/A | 19 | N/A |
| 6/30/2018 | 55 | 16 | N/A | 10 | N/A |
| 3/31/2018 | 33 | 9 | N/A | 2 | N/A |
| 12/31/2017 | 20 | 4 | N/A | 0 | N/A |
| 12/31/2016 | 0 | -4 | N/A | -4 | N/A |
애널리스트 향후 성장 전망
수입 대 저축률: TRUL 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(3%)보다 빠른 성장으로 간주됩니다.
수익 vs 시장: TRUL (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.
고성장 수익: TRUL 향후 3년 내에 수익을 낼 것으로 예상됩니다.
수익 대 시장: TRUL 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -5.5%).
고성장 매출: TRUL 의 수익은 향후 3년 동안 감소할 것으로 예상됩니다(연간 -5.5%).
주당순이익 성장 예측
향후 자기자본이익률
미래 ROE: TRUL의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.
성장 기업 찾아보기
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/06/11 09:38 |
| 종가 | 2026/06/09 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.
Simply Wall St 분석 모델을 설계하고 구축한 에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Trulieve Cannabis Corp.는 16명의 분석가가 다루고 있습니다. 이 중 7명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Aaron Grey | Alliance Global Partners |
| Frederico Yokota Choucair Gomes | ATB Cormark |
| Matt Bottomley | Canaccord Genuity |